Pleural effusions

Disease-a-Month

Volumn 59, Issue 2, 2013, Pages 29-57

  Porcel, José M ^a   Light, Richard W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATELECTASIS; CHYLOTHORAX; CLINICAL EVALUATION; CORONARY ARTERY BYPASS SURGERY; DIFFERENTIAL DIAGNOSIS; HEART FAILURE; HEMATOTHORAX; HUMAN; HYPOALBUMINEMIA; LIVER CIRRHOSIS; LUNG EMBOLISM; LYMPHOMA; MEIGS SYNDROME; PATHOGENESIS; PERICARDIAL DISEASE; PERITONEAL DIALYSIS; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA FLUID; PLEURA METASTASIS; PLEURA THICKENING; PNEUMONIA; REVIEW; RHEUMATIC DISEASE; THORACOCENTESIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

HUMANS; PLEURAL EFFUSION;

EID: 84873137936     PISSN: 00115029     EISSN: 15578194     Source Type: Journal    
DOI: 10.1016/j.disamonth.2012.11.002     Document Type: Review

References (111)

1. Light R.W. Pleural effusions. Med Clin North Am 2011, 95:1055-1070.
2. Khan F.Y., Alsamawi M., Yasin M., et al. Etiology of pleural effusion among adults in the state of Qatar: a 1-year hospital-based study. East Mediterr Health J 2011, 17:611-618.
3. Utine G.E., Ozçelik U., Kiper N., et al. Pediatric pleural effusions: etiological evaluation in 492 patients over 29 years. Turk J Pediatr 2009, 51:214-219.
4. Noppen M. Composition of normal pleural fluid. Int Pleural Newsl 2006, 4:13. Available from http://www.musc.edu/pleuralnews/IPN/.
5. Porcel J.M., Light R.W. Diagnostic approach to pleural effusion in adults. Am Fam Physician 2006, 73:1211-1220.
6. Brims F.J.H., Davies H.E., Gary Lee Y.C. Respiratory chest pain: diagnosis and treatment. Med Clin North Am 2010, 94:217-232.
7. Wong C.L., Holroyd-Leuc J., Straus S.E. Does this patient have a pleural effusion?. JAMA 2009, 301:309-317.
8. McGee S. Evidence-Based Physical Diagnosis 2012, Elsevier Saunders, Philadelphia, pp. 288-290.
9. Light R.W. Pleural Diseases 2007, Lippincott Williams & Wilkins, Philadelphia. 5th ed.
10. Porcel J.M. Pleural effusions from congestive heart failure. Semin Respir Crit Care Med 2010, 31:689-697.
11. Porcel J.M., Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 2003, 124:978-983.
12. Brixey A.G., Luo Y., Skouras V., Awdankiewicz A., Light R.W. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011, 16:1000-1004.
13. Lisi M., Cameli M., Mondillo S., et al. Incremental value of pocket-sized imaging device for bedside diagnosis of unilateral pleural effusions and ultrasound-guided thoracentesis. Interact Cardiovasc Thorac Surg 2012, 15:596-601.
14. Zanobetti M., Poggioni C., Pini R. Can chest ultrasonography replace standard chest radiography for evaluation of acute dyspnea in the emergency department?. Chest 2011, 139:1140-1147.
15. Qureshi N.R., Rahman N.M., Gleeson F.V. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009, 64:139-143.
16. Koenig S.J., Narasimhan M., Mayo P.H. Thoracic ultrasonography for the pulmonary specialist. Chest 2011, 140:1332-1341.
17. Raj V., Kirke R., Bankart M.J., Entwisle J.J., Multidetector C.T. imaging of pleura: comparison of two contrast infusion protocols. Br J Radiol 2011, 84:796-799.
18. Yilmaz U., Polat G., Sahin N., Soy O., Gülay U.C.T. In differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis 2005, 63:17-22.
19. Seely J.M., Nguyen E.T., Churg A.M., Müller N.L. Malignant pleural mesothelioma: computed tomography and correlation with histology. Eur J Radiol 2009, 70:485-491.
20. Metintas M., Ucgun I., Elbek O., et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 2002, 41:1-9.
21. Helm E.J., Matin T.N., Gleeson F.V. Imaging of the pleura. J Magn Reson Imaging 2010, 32:1275-1286.
22. Duysinx B., Nguyen D., Louis R., et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 2004, 125:489-493.
23. Duyxinx B.C., Larock M.P., Nguyen D., et al. 18-FDG PET imaging in assessing exudative pleural effusions. Nucl Med Commun 2006, 27:971-976.
24. Francis R., Segard T., Morandeau L. Novel molecular imaging in lung and pleural diseases. Respirology 2011, 16:1173-1188.
25. Porcel JM. The diagnostic utility of pleural fluid tests in clinical practice. Curr Respir Med Rev. 2012;8:383-390.
26. Villena V., López-Encuentra A., García-Luján R., Echave-Sustaeta J., Martínez C.J. Clinical implications of appearance of pleural fluid at thoracentesis. Chest 2004, 125:156-159.
27. Menzies S.M., Rahman N.M., Wrightson J.M., et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011, 66:658-662.
28. Light R.W. Pleural diseases. Dis Month 1992, 38:266-331.
29. Jenkinson F., Murphy M.J. Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of results. Ann Clin Biochem 2007, 44:471-473.
30. Porcel J.M. Pearls and myths in pleural fluid analysis. Respirology 2011, 16:44-52.
31. Bielsa S., Porcel J.M., Castellote J., Mas E., Esquerda A., Light R.W. Solving the Light's criteria misclassification rate of cardiac and hepatic transudates. Respirology 2012, 17:721-726.
32. Porcel JM. Pleural fluid biomarkers: beyond Light's criteria. Clin Chest Med, in press.
33. Oba Y., Abu-Salah T. The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration 2012, 83:198-208.
34. Sahn S.A. Getting the most from pleural fluid analysis. Respirology 2012, 17:270-277.
35. Bielsa S., Salud A., Martínez M., et al. Prognostic significance of pleural fluid data in patients with malignant effusion. Eur J Intern Med 2008, 19:334-339.
36. Porcel J.M., Esquerda A., Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010, 21:419-423.
37. Tsai T.H., Shih J.Y. EGFR mutations in malignant effusions from lung cancer. Int Pleural Newsl 2012, 10:7-8. Available from http://www.musc.edu/pleuralnews/IPN/.
38. Porcel J.M., Esquerda A., Falguera M., Ruiz-González A., Bielsa S. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med 2012, 23:447-450.
39. Porcel J.M. Tuberculous pleural effusion. Lung 2009, 187:263-270.
40. Porcel J.M., Vives M., Esquerda A., Salud A., Pérez B., Rodríguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004, 126:1757-1763.
41. Hooper CE, Morley AJ, Virgo P, Harvey JE, Kahan B, Maskell NA. A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions. Eur Respir J, in press.
42. Pass H.I., Levin S.M., Harbut M.R., et al. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med 2012, 367:1417-1427.
43. Friedrich S.O., von Groote-Bidlingmaier F., Diacon A.H. Xpert MTB/RIF assay for diagnosis of pleural tuberculosis. J Clin Microbiol 2011, 49:4341-4342.
44. Prakash U.B., Reiman H.M. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1995, 60:158-164.
45. Koegelenberg C.F.N., Diacon A.H. Pleural controversy: closed needle pleural biopsy or thoracoscopy-which first?. Respirology 2011, 16:738-746.
46. Loddenkemper R., Mathur P., Noppen M., Lee P. Medical thoracoscopy/pleuroscopy: manual and atlas 2011, Thieme, Stuttgart.
47. Wrightson J.M., Davies H.E. Outcome of patients with nonspecific pleuritis at thoracoscopy. Curr Opin Pulm Med 2011, 17:242-246.
48. Brixey A.G., Light R.W. Pleural effusions occurring with right heart failure. Curr Opin Pulm Med 2011, 17:226-231.
49. Porcel J.M. Establishing a diagnosis of pleural effusion due to heart failure. Respirology 2009, 14:471-473.
50. Porcel J.M. Utilization of B-type natriuretic peptide and NT-proBNP in the diagnosis of pleural effusions due to heart failure. Curr Opin Pulm Med 2011, 17:215-219.
51. Porcel JM, Bielsa S, Morales JL, et al. Comparison of pleural fluid NT-proBNP, MR-proANP and MR-proADM for the diagnosis of cardiac effusions. Respirology, in press.
52. Krok K.L., Cárdenas A. Hepatic hydrothorax. Semin Respir Crit Care Med 2012, 33:3-10.
53. Castellote-Alonso J. Pleural effusion in liver disease. Semin Respir Crit Care Med 2010, 31:698-705.
54. Tu C.Y., Chen C.H. Spontaneous bacterial empyema. Curr Opin Pulm Med 2012, 18:355-358.
55. Cellerin L., Marcq M., Sagan C., Chailleux E. Pleurésies malignes révélatrices d'un cancer: des étiologies avec les pleurésies métastatiques d'un cancer connu. Rev Mal Respir 2008, 25:1104-1109.
56. Porcel J.M., Rodriguez-Panadero F. Malignant effusions. Oxford Desk Reference Respiratory Medicine 2009, 342-344. Oxford University Press, Oxford. N. Maskell, A. Millar (Eds.).
57. 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma. Oncol Rep 2012, 27:333-338.
58. Finn RS, Brims FJ, Gandhi A, et al. Post mortem findings of malignant pleural mesothelioma: a two-center study of 318 patients. Chest. 2012;142:1267-1273.
59. Chen S.E., Pace M.B. Malignant pleural mesothelioma. Am J Health-Syst Pharm 2012, 69:377-385.
60. Heffner J.E. Management of the patient with a malignant pleural effusion. Semin Respir Crit Care Med 2010, 31:723-733.
61. Hsia D., Musani A.I. Management of malignant pleural effusions. Curr Respir Care Rep 2012, 1:73-81.
62. Hirata T., Yonemori K., Hirakawa A., et al. Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. Eur Respir J 2011, 38:1425-1430.
63. Rodríguez-Panadero F., Montes-Worboys A. Mechanisms of pleurodesis. Respiration 2012, 83:91-98.
64. Astoul P. Pleurodesis for malignant pleural effusions: the quest for the Holy Grail. Eur J Cardiothorac Surg 2011, 40:277-279.
65. Arellano-Oden E, Romero-Falcon A, Juan JM, Ocaña-Jurado M, Rodriguez-Panadero F, Montes-Worboys A Small-particle size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis. Respiration, DOI: http://dx.doi.org/10.1159/000342042.
66. Light R.W. Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No. Chest 2012, 142:17-20.
67. Bielsa S., Porcel J.M. Doxycycline pleurodesis. Int Pleural Newsl 2010, 8:17-18. Available from http://www.musc.edu/pleuralnews/IPN/.
68. Bielsa S., Hernández P., Rodríguez-Panadero F., Taberner T., Salud A., Porcel J.M. Tumor type influences the effectiveness of pleurodesis in malignant effusions. Lung 2011, 189:151-155.
69. Chee A., Tremblay A. The use of tunneled pleural catheters in the treatment of pleural effusions. Curr Opin Pulm Med 2011, 17:237-241.
70. MacEacher P., Tremblay A. Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions. Respirology 2011, 16:747-754.
71. Van Meter M.E., McKee K.Y., Kohlwes R.J. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 2011, 26:70-76.
72. Davies H.E., Mishra E.K., Kahan B.C., et al. Effect of and indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012, 307:2383-2389.
73. Reddy C., Ernst A., Lamb C., Feller-Kopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest 2011, 139:1419-1423.
74. Porcel J.M., Light R.W. Parapneumonic pleural effusions and empyema in adults: current practice. Rev Clin Esp 2009, 209:485-494.
75. Falguera M., Carratalá J., Bielsa S., et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusions. Eur Respir J 2011, 38:1173-1179.
76. Davies H.E., Davies R.J.O., Davies C.W.H. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010, 65:ii41-ii53.
77. Janda S., Swiston J. Intrapleural fibrinolytic therapy for treatment for adults parapneumonic effusions and empyemas. A systematic review and meta-analysis. Chest 2012, 142:401-411.
78. Maskell N.A., Davies C.W.H., Nunn J., et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005, 352:865-874.
79. Rahman N.M., Maskell N., West A., et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011, 365:518-526.
80. Valdés L., San José M.A., Pose A., et al. Diagnosing tuberculous pleural effusion using clinical data and pleural fluid analysis. A study of patients less than 40-years old in an area with a high incidence of tuberculosis. Respir Med 2010, 104:1211-1217.
81. Bielsa S., Palma R., Pardina M., Esquerda A., Light R.W., Porcel J.M. Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions. Int J Tuberc Lung Dis 2013, 17:85-89.
82. Porcel J.M., Light R.W. Pleural effusions due to pulmonary emboli. Curr Opin Pulm Med 2008, 14:337-342.
83. Porcel J.M., Madroñero A.B., Pardina M., Vives M., Esquerda A., Light R.W. Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients. Respirology 2007, 12:234-239.
84. Light R.W. Pleural effusion in pulmonary embolism. Semin Respir Crit Care Med 2010, 31:716-722.
85. Imazio M. The postpericardiotomy syndrome. Curr Opin Pulm Med 2012, 18:366-374.
86. Villena V, Cases E, Porcel JM, et al. Diagnosis and treatment of pleural effusion. Arch Bronconeumol, in press.
87. Light R.W. Pleural effusions after coronary artery bypass graft surgery. Int Pleural Newsl 2008, 6:11-12. Available from http://www.musc.edu/pleuralnews/IPN/.
88. Ferreiro L., Alvarez-Dobaño J.M., Valdés L. Systemic diseases and the pleura. Arch Bronconeumol 2011, 47:361-370.
89. Mok C.C. Prevalence and outcome of lupus-associated pleural effusions. Int Pleural Newsl 2009, 7:2-3. Available from http://www.musc.edu/pleuralnews/IPN/.
90. Porcel J.M., Ordi-Ros J., Esquerda A., et al. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 2007, 16:25-27.
91. Avnon L.S., Abu-Shrakra M. Pleural effusion associated with rheumatoid arthritis. Int Pleural Newsl 2009, 7:1-2. Available from http://www.musc.edu/pleuralnews/IPN/.
92. Ryu J.H., Tomassetti S., Maldonado F. Update on uncommon pleural effusions. Respirology 2011, 16:238-243.
93. Porcel JM. Chylothorax and cholesterol effusion. In: Grippi, Heffner, Kotloff, eds. Clinical Decision Support: Pulmonary Medicine. Wilmington, North Carolina, in press.
94. Huggins J.T. Chylothorax and cholesterol effusions. Semin Respir Crit Care Med 2010, 31:743-750.
95. Boersma W.G., Stigt J.A., Smit H.J. Treatment of haemothorax. Respir Med 2010, 104:1583-1587.
96. Machado N.O. Pancreaticopleural fistula: revisited. Diagn Ther Endosc 2012, 815476.
97. Huggins J.T., Doelken P., Sahn S.A. The unexpandable lung. F1000 Med Rep 2010, 2:77.
98. Light R.W., Doelken P. Diagnosis and management of pleural causes of unexpandable lung. UptoDate 2012, http://www.uptodate.com/.
99. Celik S., Celik M., Aydemir B., Tunckaya C., Okay T., Dogusoy I. Long-term results of lung decortication in patients with trapped lung secondary to coronary artery bypass grafting. Ann Thorac Cardiovasc Surg 2012, 18:109-114.
100. Rashid-Farokhi F., Pourdowlat G., Nikoonia M.R., et al. Uremic pleuritis in chronic hemodialysis patients. Hemodial Int 2013, 17:94-100.
101. Bakirci T., Sasak G., Ozturk S., Akcay S., Sezer S., Haberal M. Pleural effusions in long-term hemodialysis patients. Transplant Proc 2007, 39:889-891.
102. Lew S.Q. Hydrothorax: pleural effusion associated with peritoneal dialysis. Perit Dial Int 2010, 30:13-18.
103. García-Pachón E., Romero S. Urinothorax: a new approach. Curr Opin Pulm Med 2006, 12:259-263.
104. Porcel JM, Light RW. Thoracentesis. ; 2012. Accessed 28.10.04. In: PIER [online database]. Philadelphia, American College of Physicians. http://www.pier.acponline.org.
105. Diacon A.H., Brutsche M.H., Solèr M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest 2003, 123:436-441.
106. Patel I.J., Davidson J.C., Nikolic B., et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012, 23:727-736.
107. Patel M.D., Joshi S.D. Abnormal preprocedural international normalized ratio and platelets counts are not associated with increased bleeding complications after ultrasound-guided thoracentesis. Am J Roentgenol 2011, 197:W164-W168.
108. Gordon C.E., Feller-Kopman D., Balk E.M., Smetana G.W. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med 2010, 170:332-339.
109. Yoneyama H. Intercostal artery laceration during thoracentesis. Int Pleural Newsl 2011, 9:1-2. Available from http://www.musc.edu/pleuralnews/IPN/.
110. Light R.W. Pleural controversy: optimal chest tube size for drainage. Respirology 2011, 16:244-248.
111. Davies H.E., Merchant S., McGown A. A study of the complications of small bore Seldinger intercostal chest drains. Respirology 2008, 13:603-607.